Earnings History Data for Amryt Pharma plc (AMYT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amryt Pharma plc

Amryt Pharma plc is a biopharmaceutical company. It develops and commercializes therapeutics to treat rare diseases. Amryt Pharma plc is based in London, the United Kingdom.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2022	PM	7:00 AM ET (Nov 3)	AMYT	Amryt Pharma plc	440.25	-0.06	-0.04	-0.07	Amryt Pharma GAAP EPS of -$0.06, revenue of $61.1M, reaffirms FY guidance [11/3/2022 7:21 AM]	6.87	-0.06 (-0.87%)	6.96	0.03 (0.43%)	5.61 - 12.17	38,714	20,000	400
Amryt Pharma GAAP EPS of -$0.06, revenue of $61.1M, reaffirms FY guidance [11/3/2022 7:21 AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	AMYT	Amryt Pharma plc	487.46	-0.02	-0.04	-0.04	Amryt Pharma GAAP EPS of -$0.02 beats by $0.04, revenue of $68.54M beats by $4.28M [8/4/2022 7:18 AM]	7.83	0.43 (5.74%)	3.92	-0.40 (-9.26%)	5.61 - 12.45	55,534	40,000	51,552
Amryt Pharma GAAP EPS of -$0.02 beats by $0.04, revenue of $68.54M beats by $4.28M [8/4/2022 7:18 AM] Amryt Reports Record Q2 2022 Results [Aug-04-22 07:00AM]
04-05-2022	PM	7:00 AM ET (May 4)	AMYT	Amryt Pharma	537.00	-0.05	-0.05	0.00	Amryt Pharma GAAP EPS of -$0.05, revenue of $59.13M; reaffirms FY22 guidance [5/4/2022 7:08 AM]	8.48	0.0 (0.00%)	0.0	0.0 (0.00%)	5.61 - 13.45	67,763	80,000	0
Amryt Pharma GAAP EPS of -$0.05, revenue of $59.13M; reaffirms FY22 guidance [5/4/2022 7:08 AM] Amryt Reports Record Q1 2022 Results [May-04-22 07:00AM]
09-03-2022	PM	0:00 AM ET (Mar 9)	AMYT	Amryt Pharma plc	402.97	0.15	-0.14	-0.28	Amryt Pharma GAAP EPS of $0.07 beats by $0.12, revenue of $54.8M misses by $1.8M [3/9/2022 7:59 AM]	6.99	0.47 (7.21%)	0.0	0.0 (0.00%)	5.61 - 15.42	80,034	410,000	0
Amryt's Mycapssa found safe in phase 1 trial; plans late-stage study [3/8/2022 8:08 AM] Amryt Pharma GAAP EPS of $0.07 beats by $0.12, revenue of $54.8M misses by $1.8M [3/9/2022 7:59 AM] Amryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules) [Mar-08-22 07:00AM]
03-11-2021	PM		AMYT	Amryt Pharma	685.00	-0.07	-0.21	0.00	Amryt Pharma reports Q3 results; reaffirms full year guidance [11/3/2021 9:11 AM]	11.30	0.18 (1.62%)	0.0	0.0 (0.00%)	9.55 - 15.44	530,543	180,000	0
Amryt Pharma reports Q3 results; reaffirms full year guidance [11/3/2021 9:11 AM] Amryt Reports Strong Q3 2021 Results [Nov-03-21 07:00AM] Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-21 08:35AM]
05-05-2021	PM		AMYT	Amryt Pharma plc	472.78	-0.09	0.00	-0.19	Amryt Pharma reports Q1 results [5/5/2021 7:16 AM]	11.50	-1.34 (-10.44%)	11.50	-1.34 (-10.44%)	10.06 - 15.50	548,875	40,000	55,851
Amryt Pharma reports Q1 results [5/5/2021 7:16 AM] Chiasma surges on merger agreement with Amryt [5/5/2021 9:28 AM] Amryt Pharma Plc - ADR to Host Earnings Call [May-05-21 06:45AM] Amryt Reports Record Q1 2021 Financial and Operating Results [May-05-21 07:05AM] Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases [May-05-21 07:00AM] Chiasma Stock Shoots Up On Being Acquired By Amryt Pharma In All Stock Deal [May-05-21 07:52AM] ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc. [May-05-21 05:36PM] SHAREHOLDER ALERT: WeissLaw LLP Investigates Chiasma, Inc. [May-05-21 05:30PM]
05-11-2020	PM		AMYT	Amryt Pharma plc	413.52	-0.07	0.00	0.00	Amryt Pharma reports Q3 results [11/5/2020 7:30 AM]	13.49	0.79 (6.22%)	13.30	0.60 (4.72%)	7.90 - 15.50	62,904	27,939	200

06-08-2020	PM	Before the open (Aug 6)	AMYT	Amryt Pharma plc	356.62	-0.12	0.00	0.00		11.25	0.12 (1.12%)	11.80	0.68 (6.07%)	7.90 - 15.50	9,378	14,873	300